{"id":"https://openalex.org/W2393699321","doi":null,"title":"Efficacy and Safety of Saxagliptin in Type 2 Diabetes Patients Poorly Controlled with Insulin","display_name":"Efficacy and Safety of Saxagliptin in Type 2 Diabetes Patients Poorly Controlled with Insulin","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2393699321","mag":"2393699321"},"language":"en","primary_location":{"id":"mag:2393699321","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=PLHY201406019","pdf_url":null,"source":{"id":"https://openalex.org/S2764472741","display_name":"Chinese Journal of Clinical Rational Drug Use","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730451","host_organization_name":"Hebei Science and Technology Association","host_organization_lineage":["https://openalex.org/P4361730451"],"host_organization_lineage_names":["Hebei Science and Technology Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Clinical Rational Drug Use","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2393699321"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051668484","display_name":"Wang Yon","orcid":"https://orcid.org/0000-0001-8473-5386","observed_orcids":["https://orcid.org/0000-0001-8473-5386"]},"institutions":[{"id":"https://openalex.org/I100357981","display_name":"Wannan Medical College","ror":"https://ror.org/037ejjy86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I100357981"]},{"id":"https://openalex.org/I4210167381","display_name":"First Affiliated Hospital of Wannan Medical College","ror":"https://ror.org/05wbpaf14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210167381"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Wang Yon","raw_affiliation_strings":["Department of Endocrinology,Yijishan Hospital Affiliated to Wannan Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology,Yijishan Hospital Affiliated to Wannan Medical College","institution_ids":["https://openalex.org/I100357981","https://openalex.org/I4210167381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5051668484"],"corresponding_institution_ids":["https://openalex.org/I100357981","https://openalex.org/I4210167381"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.550000011920929},{"id":"https://openalex.org/keywords/poor-glycemic-control","display_name":"poor glycemic control","score":0.9049999713897705},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.699999988079071},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8690000176429749},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/homa-ir","display_name":"HOMA-IR","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8870000243186951},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.7409999966621399},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9432483911514282},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.8629341125488281},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.8354417085647583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7787454128265381},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6648027896881104},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.6359277367591858},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6331907510757446},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6102765202522278},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5871078372001648},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4844386875629425},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.4736807644367218},{"id":"https://openalex.org/C2780485761","wikidata":"https://www.wikidata.org/wiki/Q275157","display_name":"Blood sugar","level":3,"score":0.44913968443870544},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.3432815372943878},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.18189570307731628}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2393699321","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=PLHY201406019","pdf_url":null,"source":{"id":"https://openalex.org/S2764472741","display_name":"Chinese Journal of Clinical Rational Drug Use","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730451","host_organization_name":"Hebei Science and Technology Association","host_organization_lineage":["https://openalex.org/P4361730451"],"host_organization_lineage_names":["Hebei Science and Technology Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Clinical Rational Drug Use","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2009999012","https://openalex.org/W1984805650","https://openalex.org/W2114927834","https://openalex.org/W1980605868","https://openalex.org/W2094058771","https://openalex.org/W2047041946","https://openalex.org/W3030900679","https://openalex.org/W2380051185","https://openalex.org/W2802463458","https://openalex.org/W2003316205"],"abstract_inverted_index":{"Objective":[0],"The":[1,80,186],"course":[2],"of":[3,19,44,110,121,131,145,162,167,208,261,268,273],"the":[4,62,68,97,103,108,122,228,259,266],"disease":[5],"was":[6,180,198,232],"observed":[7],"in":[8,102,156,190,246,250],"patients":[9,46,63,163,251],"with":[10,30,47,75,93,252],"type":[11,48,253],"2":[12,49,254],"diabetes":[13,50,255],"use":[14,109,224],"insulin":[15,94,116,146,223,240,263,278],"more":[16],"than":[17,175,227],"5years":[18],"non-":[20],"union":[21],"dipeptidyl":[22],"peptidase":[23],"4(":[24],"DPP-":[25,242],"4)":[26],"inhibitors,saxagliptin":[27],"when":[28],"added":[29],"poor":[31,247],"glycemic":[32,248],"control,blood":[33],"sugar":[34],"control":[35,71,81,92,229,249,272],"and":[36,73,117,126,154,194,222],"improve":[37,277],"islet":[38],"function":[39],"effect.":[40],"Methods":[41],"A":[42],"total":[43],"64":[45],"who":[51],"were":[52,64,225],"admitted":[53],"to":[54,84,87,95,276],"our":[55],"hospital":[56],"from":[57],"January":[58,60],"2012":[59],"2013,then":[61],"randomly":[65],"divided":[66],"into":[67],"original":[69,104],"program(":[70],"group)":[72],"processing":[74],"saxagliptin":[76],"group(":[77],"experimental":[78,100,187,210],"group).":[79],"group":[82,101,188,211],"continued":[83],"increase":[85],"according":[86],"blood":[88,90,118,133,169,213,217,274],"glucose":[89,91,214,275],"achieve":[96],"stated":[98],"objectives,the":[99],"scheme":[105],"based":[106,114],"on":[107,115],"saxagliptin,saxagliptin":[111],"dose":[112],"adjustment":[113],"glucose.":[119],"Comparison":[120],"two":[123],"groups":[124,161],"before":[125,176,193],"after":[127,164,195],"treatment":[128,177],"12":[129,165,206],"weeks":[130,166,207],"fasting":[132,212],"glucose,postprandial":[134,170],"2h":[135,171],"plasma":[136,172],"glucose,glycated":[137],"hemoglobin(":[138],"HbA1c),fasting":[139],"C-":[140,220],"peptide,fasting":[141],"insulin,homeostasis":[142],"model":[143],"assessment":[144],"resistance":[147],"index(":[148],"HOMA-":[149],"IR),insulin":[150],"daily":[151,262],"dose,body":[152],"weight":[153,192],"changes":[155,189],"hypoglycemic":[157],"events.":[158],"Results":[159],"Two":[160],"treatment,fasting":[168],"glucose,HbA1c,HOMA-":[173,218],"IR":[174],"decreased,the":[178],"difference":[179,197,231],"statistically":[181,200,233],"significant(":[182,234],"P":[183,202,235],"0.":[184,203,236],"05);":[185],"body":[191],"treatment,the":[196],"not":[199],"significance(":[201],"05).":[204,237],"After":[205],"treatment,The":[209],"test,2h":[215],"postprandial":[216],"IR,fasting":[219],"peptide":[221],"lower":[226],"group,the":[230],"Conclusion":[238],"Non-":[239],"combined":[241],"4":[243],"inhibitor":[244],"therapy":[245],"plus":[256],"saxagliptin,significantly":[257],"reduced":[258],"amount":[260],"use,without":[264],"increasing":[265],"risk":[267],"hypoglycemia":[269],"premise":[270],"effective":[271],"resistance.":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2393699321","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
